Omnia SanaPlant Comparison
Saffron vs Rhodiola Rosea
A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.
At a glance
Saffron and Rhodiola Rosea: they share 7 indicated uses (arthritis / joint pain, blood sugar / diabetes support, cognitive function, …); 4 pharmacological actions in common.
Evidence face-off — shared uses
| Condition | Saffron | Rhodiola Rosea | Verdict |
|---|---|---|---|
| Arthritis / joint pain | 1/10 | 6/10 | Stronger for Rhodiola Rosea |
| Blood sugar / diabetes support | 1/10 | 6/10 | Stronger for Rhodiola Rosea |
| Cognitive function | 1/10 | 9/10 | Stronger for Rhodiola Rosea |
| Inflammation (general) | 1/10 | 9/10 | Stronger for Rhodiola Rosea |
| Memory | 1/10 | 6/10 | Stronger for Rhodiola Rosea |
| Metabolic support | 1/10 | 6/10 | Stronger for Rhodiola Rosea |
| Skin irritation | 1/10 | 6/10 | Stronger for Rhodiola Rosea |
Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.
Key Constituents
Water-soluble carotenoid glycosides responsible for saffron's deep golden-red colour and much of its antioxidant and mood-related activity.
The principal volatile aromatic compound, giving saffron its characteristic scent and contributing to its sedative and antidepressant activity.
The main bitter-tasting glycoside of the stigma, a precursor of safranal.
Characteristic phenylpropanoid glycosides largely unique to Rhodiola rosea, used as a standardisation marker for commercial extracts.
Phenylethanoid glycosides considered key adaptogenic and antioxidant constituents.
Contribute to the anti-inflammatory and antioxidant activity of the root.
Pharmacological Actions
Traditional & Indicated Uses
inferred from anti-inflammatory action
inferred from antidiabetic action
inferred from anticancer action
inferred from neuroprotective action
inferred from anti-inflammatory action
inferred from sedative action
inferred from antidiabetic action
inferred from anti-inflammatory action
inferred from antidiabetic action
inferred from neuroprotective action
inferred from immunomodulator action
inferred from ergogenic action
inferred from anti-inflammatory action
inferred from ergogenic action
Safety, Cautions & Contraindications
Culinary use is entirely safe. At very high doses (5g+), saffron can be toxic — but such doses far exceed culinary or therapeutic amounts. Avoid medicinal doses during pregnancy (uterine stimulant). May interact with antidepressants. High quality saffron is often adulterated; verify source.
Duke (2002) rates saffron as ++ and provides a critical safety warning: abortifacient activity has clinical support (score 2), meaning that medicinal doses can induce abortion — saffron is strictly contraindicated in pregnancy at doses above culinary amounts. The plant also shows antidepressant, antioxidant, and antitumor activities at the experimental level (score 1). Dose (culinary): 0.5 g stigmas as flavoring; medicinal doses above 5 g are considered potentially toxic. Duke notes that saffron stigmas contain crocin and safranal, which are responsible for its antidepressant and antioxidant properties (Duke, 2002).
Generally well tolerated. May cause agitation, insomnia, or vivid dreams in sensitive individuals — take in the morning. Avoid in manic episodes or severe anxiety. Theoretical interactions with MAOIs, SSRIs, and CNS stimulants. Avoid during pregnancy and breastfeeding.
External Ids
Botanical Description
Small, cormous perennial with narrow, grass-like, dark green leaves emerging with or just after the flowers. Each flower is a delicate lilac-purple, six-petalled bloom with three golden-yellow anthers and a single style dividing into three long, deep-red, thread-like stigmas - the saffron of commerce. The plant is a sterile triploid that never sets seed and is propagated entirely by division of its underground corms.
Succulent perennial herb (Crassulaceae), 15-40 cm tall, with a thick, fleshy, branching rhizome that has a rose-like fragrance when cut - the origin of the name 'rosea'. Leaves are fleshy, greyish-green, oval to oblong. Small yellow (occasionally reddish) flowers are clustered in dense terminal heads; the species is dioecious, with separate male and female plants. Fruit follicles turn red as they ripen.[3]
Habitat
Believed to have originated in Greece or Crete and spread through cultivation across the Mediterranean, Middle East and Asia (notably Iran, Kashmir and Spain); grown in sunny, well-drained fields with hot, dry summers and cool, wet autumns/winters.
Native to arctic and mountainous regions of Europe, Asia and North America (circumpolar), growing in cold, rocky, high-altitude or high-latitude terrain - cliffs, rocky slopes and tundra - tolerating harsh, exposed conditions.[3]
Harvesting
The flowers are hand-picked at dawn as they open, and the three red stigma threads are immediately hand-separated from each flower and dried - an extremely labour-intensive process (many thousands of flowers are needed for a small amount of dried saffron), which accounts for saffron's high cost.
Rhizome and root are dug from plants at least a few years old (traditionally 4-5 years), typically in autumn, then cleaned and dried. Wild populations grow slowly, so cultivated sources are increasingly preferred for sustainability.[3]
Traditional Uses
Saffron has a long Mediterranean, Middle Eastern and South Asian tradition as both a prized culinary spice/dye and a medicinal herb, used for mood support, digestive complaints and as a mild emmenagogue; its traditional mood-lifting reputation is now supported by clinical trials comparing standardised saffron extract to conventional antidepressants for mild-to-moderate depression.[1]
Rhodiola has a long tradition of use across Scandinavian, Russian and Central Asian folk medicine as a tonic for cold-climate hardiness, physical endurance and mental stamina. It is classified as a modern 'adaptogen', and clinical trials support benefits for stress-related fatigue, mood and cognitive performance.[1, 3]
Preparations
Stigma extract standardised to safranal/crocin content, taken as capsules; the form used in most clinical mood and metabolic studies.
Dosage
Clinical trials for mood support commonly use around 30 mg of standardised saffron extract daily (in divided doses); culinary use is typically well under 1 g. High medicinal doses (5 g or more) are considered potentially toxic and should be avoided. Educational reference only, not a prescription.
References
Drug Class Interactions
Lookalikes Review
Dangerous Lookalikes
Not documented
Pairings
Not documented
Rhodiola and eleuthero (Siberian ginseng) are classic adaptogens combined in traditional and studied fixed formulas to build resistance to stress and fatigue; used together their stress-protective effects are complementary.[17, 18]
Rhodiola and schisandra are adaptogens co-formulated in clinically studied combinations for stress, fatigue and mental performance; combined use is intended to be synergistic rather than harmful.[17, 18]
References & Sources
- Shafiee, A., Jafarabady, K., Seighali, N., Mohammadi, I. et al (2025) 'Effect of Saffron Versus Selective Serotonin Reuptake Inhibitors (SSRIs) in Treatment of Depression and Anxiety: A Meta-analysis of Randomized Controlled Trials', Nutrition Reviews, 83(3), pp. e751-e761. doi:10.1093/nutrit/nuae076 Meta-analysis / review
https://doi.org/10.1093/nutrit/nuae076 - Lopresti, A.L. and Drummond, P.D (2014) 'Saffron (Crocus sativus) for depression: a systematic review of clinical studies and examination of underlying antidepressant mechanisms of action', Human Psychopharmacology, 29(6), pp. 517-527. doi:10.1002/hup.2434 Meta-analysis / review
https://doi.org/10.1002/hup.2434 - Chen, Z., Gu, J., Lin, S., Xu, Z. et al (2022) 'Saffron essential oil ameliorates CUMS-induced depression-like behavior in mice via the MAPK-CREB1-BDNF signaling pathway', Journal of Ethnopharmacology, 300, pp. 115719. doi:10.1016/j.jep.2022.115719 Preclinical
https://doi.org/10.1016/j.jep.2022.115719 - Hausenblas, H.A., Saha, D., Dubyak, P.J. and Anton, S.D (2013) 'Saffron (Crocus sativus L.) and major depressive disorder: a meta-analysis of randomized clinical trials', Journal of Integrative Medicine, 11(6), pp. 377-383. doi:10.3736/jintegrmed2013056 Meta-analysis / review
https://doi.org/10.3736/jintegrmed2013056 - Kell, G., Rao, A., Beccaria, G., Clayton, P., Inarejos-Garcia, A.M. and Prodanov, M (2017) 'affron a novel saffron extract (Crocus sativus L.) improves mood in healthy adults over 4 weeks in a double-blind, parallel, randomized, placebo-controlled clinical trial', Complementary Therapies in Medicine, 33, pp. 58-64. doi:10.1016/j.ctim.2017.06.001 Randomized trial
https://doi.org/10.1016/j.ctim.2017.06.001 - Baziar, S., Aqamolaei, A., Khadem, E., Mortazavi, S.H., Naderi, S., Sahebolzamani, E., Mortezaei, A., Jalilevand, S., Mohammadi, M., Shahmirzadi, M. and Akhondzadeh, S (2019) 'Crocus sativus L. Versus Methylphenidate in Treatment of Children with Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind Pilot Study', Journal of Child and Adolescent Psychopharmacology, 29(3), pp. 205-212. doi:10.1089/cap.2018.0146 Randomized trial
https://doi.org/10.1089/cap.2018.0146 - Moshiri, M., Vahabzadeh, M. and Hosseinzadeh, H (2014) 'Clinical Applications of Saffron (Crocus sativus) and its Constituents: A Review', Drug Research, 65(6), pp. 287-295. doi:10.1055/s-0034-1375681 Meta-analysis / review
https://doi.org/10.1055/s-0034-1375681 - Finley, J.W. and Gao, S (2017) 'A Perspective on Crocus sativus L. (Saffron) Constituent Crocin: A Potent Water-Soluble Antioxidant and Potential Therapy for Alzheimer's Disease', Journal of Agricultural and Food Chemistry, 65(5), pp. 1005-1020. doi:10.1021/acs.jafc.6b04398 Meta-analysis / review
https://doi.org/10.1021/acs.jafc.6b04398 - Boskabady, M.H. and Farkhondeh, T (2016) 'Antiinflammatory, Antioxidant, and Immunomodulatory Effects of Crocus sativus L. and its Main Constituents', Phytotherapy Research, 30(7), pp. 1072-1094. doi:10.1002/ptr.5622 Meta-analysis / review
https://doi.org/10.1002/ptr.5622 - Bhandari, P.R (2015) 'Crocus sativus L. (saffron) for cancer chemoprevention: A mini review', Journal of Traditional and Complementary Medicine, 5(2), pp. 81-87. doi:10.1016/j.jtcme.2014.10.009 Meta-analysis / review
https://doi.org/10.1016/j.jtcme.2014.10.009 - Khorasanchi, Z., Shafiee, M., Kermanshahi, F., Khazaei, M., Ryzhikov, M., Parizadeh, M.R., Kermanshahi, B., Ferns, G.A., Avan, A. and Hassanian, S.M (2018) 'Crocus sativus a natural food coloring and flavoring has potent anti-tumor properties', Phytomedicine, 43, pp. 21-27. doi:10.1016/j.phymed.2018.03.041 Meta-analysis / review
https://doi.org/10.1016/j.phymed.2018.03.041 - El Midaoui, A., Ghzaiel, I., Vervandier-Fasseur, D., Ksila, M., Zarrouk, A., Nury, T., Khallouki, F., El Hessni, A., Ibrahimi, S.O., Latruffe, N., Couture, R., Kharoubi, O., Brahmi, F., Hammami, S., Masmoudi-Kouki, O., Hammami, M., Ghrairi, T., Vejux, A. and Lizard, G (2022) 'Saffron (Crocus sativus L.): A Source of Nutrients for Health and for the Treatment of Neuropsychiatric and Age-Related Diseases', Nutrients, 14(3), pp. 597. doi:10.3390/nu14030597 Meta-analysis / review
https://doi.org/10.3390/nu14030597 - Pitsikas, N (2021) 'Crocus sativus L. Extracts and Its Constituents Crocins and Safranal; Potential Candidates for Schizophrenia Treatment?', Molecules, 26(5), pp. 1237. doi:10.3390/molecules26051237 Meta-analysis / review
https://doi.org/10.3390/molecules26051237 - Akhondzadeh, S. et al (2005) 'Comparison of Crocus sativus L'. Traditional / reference
https://scholar.google.com/scholar?q=Comparison%20of%20Crocus%20sativus%20L - Hosseinzadeh, H. and Nassiri-Asl, M (2013) 'Avicenna', 27(4), pp. 475--483. Traditional / reference
https://scholar.google.com/scholar?q=Avicenna - Moshiri, E. et al (2006) 'Crocus sativus L', pp. 607--611. Traditional / reference
https://scholar.google.com/scholar?q=Crocus%20sativus%20L - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition - Talaei, A., Hassanpour Moghadam, M., Sajadi Tabassi, S.A. and Mohajeri, S.A (2015) 'Crocin, the main active saffron constituent, as an adjunctive treatment in major depressive disorder: a randomized, double-blind, placebo-controlled, pilot clinical trial', Journal of Affective Disorders, 174, pp. 51-56. doi:10.1016/j.jad.2014.11.035 Randomized trial
https://doi.org/10.1016/j.jad.2014.11.035 - Toth, B., Hegyi, P., Lantos, T., Szakacs, Z., Keremi, B., Varga, G., Tenk, J., Petervari, E., Balasko, M., Rumbus, Z., Rakonczay, Z., Balint, E.R., Kiss, T. and Csupor, D (2019) 'The efficacy of saffron in the treatment of mild to moderate depression: a meta-analysis', Planta Medica, 85(1), pp. 24-31. doi:10.1055/a-0660-9565 Meta-analysis / review
https://doi.org/10.1055/a-0660-9565 - Ghasemzadeh Rahbardar, M. and Hosseinzadeh, H (2024) 'Therapeutic potential of hypnotic herbal medicines: A comprehensive review', Phytotherapy Research, 38(6), pp. 3037-3059. doi:10.1002/ptr.8201 Meta-analysis / review
https://doi.org/10.1002/ptr.8201 - Block, K.I., Gyllenhaal, C. and Mead, M.N (2004) 'Safety and efficacy of herbal sedatives in cancer care', Integrative Cancer Therapies, 3(2), pp. 128-148. doi:10.1177/1534735404265003 Meta-analysis / review
https://doi.org/10.1177/1534735404265003 - Liu, J., Yang, Y. and Qi, Y (2024) 'Effect of saffron supplementation on the glycemic outcomes in diabetes: a systematic review and meta-analysis', Frontiers in Nutrition, 11, pp. 1349006. doi:10.3389/fnut.2024.1349006 Meta-analysis / review
https://doi.org/10.3389/fnut.2024.1349006 - Kupper, J. and Reichert, C (2009) 'Intoxications with plants', Therapeutische Umschau, 66(5), pp. 343-8. doi:10.1024/0040-5930.66.5.343 Clinical study
https://doi.org/10.1024/0040-5930.66.5.343 - Gabrscek, L. and Lesnicar, G. and Krivec, B. and Voga, G. and Sibanc, B. and Blatnik, J. and Jagodic, B (2004) 'Accidental poisoning with autumn crocus', Journal of Toxicology. Clinical Toxicology, 42(1), pp. 85-8. doi:10.1081/clt-120028750 Clinical study
https://doi.org/10.1081/clt-120028750 - University of Wisconsin-Madison Division of Extension 'Autumn Crocus, Colchicum spp'. Available at: https://hort.extension.wisc.edu/articles/autumn-crocus-colchicum-spp/ Traditional / reference
https://hort.extension.wisc.edu/articles/autumn-crocus-colchicum-spp/ - Ohio State University Extension (Buckeye Yard and Garden onLine) 'Crocus By Other Names'. Available at: https://bygl.osu.edu/node/1458 Traditional / reference
https://bygl.osu.edu/node/1458
- Ivanova Stojcheva, E. and Quintela, J.C (2022) 'The Effectiveness of Rhodiola rosea L. Preparations in Alleviating Various Aspects of Life-Stress Symptoms and Stress-Induced Conditions - Encouraging Clinical Evidence', Molecules, 27(12), pp. 3902. doi:10.3390/molecules27123902 Meta-analysis / review
https://doi.org/10.3390/molecules27123902 - Pu, W.L., Zhang, M.Y., Bai, R.Y., Sun, L.K. and others (2019) 'Anti-inflammatory effects of Rhodiola rosea L.: A review', Biomedicine & Pharmacotherapy, 121, pp. 109552. doi:10.1016/j.biopha.2019.109552 Meta-analysis / review
https://doi.org/10.1016/j.biopha.2019.109552 - Panossian, A., Wikman, G. and Sarris, J (2010) 'Rosenroot (Rhodiola rosea): traditional use, chemical composition, pharmacology and clinical efficacy', Phytomedicine, 17(7), pp. 481-493. doi:10.1016/j.phymed.2010.02.002 Meta-analysis / review
https://doi.org/10.1016/j.phymed.2010.02.002 - Tinsley, G.M., Jagim, A.R., Potter, G.D.M., Garner, D. and Galpin, A.J (2023) 'Rhodiola rosea as an adaptogen to enhance exercise performance: a review of the literature', The British Journal of Nutrition, 131(3), pp. 461-473. doi:10.1017/S0007114523001988 Meta-analysis / review
https://doi.org/10.1017/S0007114523001988 - Cropley, M., Banks, A.P. and Boyle, J (2015) 'The Effects of Rhodiola rosea L. Extract on Anxiety, Stress, Cognition and Other Mood Symptoms', Phytotherapy Research, 29(12), pp. 1934-1939. doi:10.1002/ptr.5486 Randomized trial
https://doi.org/10.1002/ptr.5486 - Amsterdam, J.D. and Panossian, A.G (2016) 'Rhodiola rosea L. as a putative botanical antidepressant', Phytomedicine, 23(7), pp. 770-783. doi:10.1016/j.phymed.2016.02.009 Meta-analysis / review
https://doi.org/10.1016/j.phymed.2016.02.009 - Olsson, E.M., von Scheele, B. and Panossian, A.G (2009) 'A randomised, double-blind, placebo-controlled, parallel-group study of the standardised extract SHR-5 of the roots of Rhodiola rosea in the treatment of subjects with stress-related fatigue', Planta Medica, 75(2), pp. 105-112. doi:10.1055/s-0028-1088346 Randomized trial
https://doi.org/10.1055/s-0028-1088346 - Ishaque, S., Shamseer, L., Bukutu, C. and Vohra, S (2012) 'Rhodiola rosea for physical and mental fatigue: a systematic review', BMC Complementary and Alternative Medicine, 12, pp. 70. doi:10.1186/1472-6882-12-70 Meta-analysis / review
https://doi.org/10.1186/1472-6882-12-70 - Borgonetti, V., Governa, P., Biagi, M., Dalia, P. and Corsi, L (2019) 'Rhodiola rosea L. modulates inflammatory processes in a CRH-activated BV2 cell model', Phytomedicine, 68, pp. 153143. doi:10.1016/j.phymed.2019.153143 Preclinical
https://doi.org/10.1016/j.phymed.2019.153143 - Coors, A., Brosch, M., Kahl, E., Khalil, R. and others (2019) 'Rhodiola rosea root extract has antipsychotic-like effects in rodent models of sensorimotor gating', Journal of Ethnopharmacology, 235, pp. 320-328. doi:10.1016/j.jep.2019.02.031 Preclinical
https://doi.org/10.1016/j.jep.2019.02.031 - Darbinyan, V. et al (2000) 'Rhodiola rosea in stress induced fatigue — a double blind cross-over study of a standardized extract SHR-5', 7(5), pp. 365--371. Randomized trial
https://scholar.google.com/scholar?q=Rhodiola%20rosea%20in%20stress%20induced%20fatigue%20%E2%80%94%20a%20double%20blind%20cross-over%20study%20of%20a%20standardized%20extract%20SHR-5 - Kelly, G.S (2001) 'Rhodiola rosea: a possible plant adaptogen', 6(3), pp. 293--302. Traditional / reference
https://scholar.google.com/scholar?q=Rhodiola%20rosea%3A%20a%20possible%20plant%20adaptogen - Panossian, A., Wikman, G. and Sarris, J (2010) 'Rosenroot (Rhodiola rosea): traditional use, chemical composition, pharmacology and clinical efficacy', 17(7), pp. 481--493. doi:10.1016/j.phymed.2010.02.002 Randomized trial
https://doi.org/10.1016/j.phymed.2010.02.002 - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition - Maniscalco, I., Toffol, E., Giupponi, G. and Conca, A (2014) 'The interaction of Rhodiola rosea and antidepressants. A case report', Neuropsychiatrie, 29(1), pp. 36-38. doi:10.1007/s40211-014-0124-8 Clinical study
https://doi.org/10.1007/s40211-014-0124-8 - van Diermen, D., Marston, A., Bravo, J., Reist, M., Carrupt, P.A. and Hostettmann, K (2009) 'Monoamine oxidase inhibition by Rhodiola rosea L. roots', Journal of Ethnopharmacology, 122(2), pp. 397-401. doi:10.1016/j.jep.2009.01.007 Preclinical
https://doi.org/10.1016/j.jep.2009.01.007 - Panossian, A.G (2013) 'Adaptogens in mental and behavioral disorders', Psychiatric Clinics of North America, 36(1), pp. 49-64. doi:10.1016/j.psc.2012.12.005 Meta-analysis / review
https://doi.org/10.1016/j.psc.2012.12.005 - Karosanidze, I., Kiladze, U., Kirtadze, N., Giorgadze, M. and Panossian, A (2022) 'Efficacy of Adaptogens in Patients with Long COVID-19: A Randomized, Quadruple-Blind, Placebo-Controlled Trial', Pharmaceuticals, 15(3), pp. 345. doi:10.3390/ph15030345 Randomized trial
https://doi.org/10.3390/ph15030345
Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.